Repare Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | $0.02 | $0.02 | $0.02 |
| Q2 2024 | 3 | -$1.46 | -$0.23 | -$0.87 |
| Q3 2024 | 1 | -$1.46 | -$0.23 | -$0.87 |
| Q4 2024 | 3 | -$1.05 | -$0.73 | -$0.83 |
| Q1 2025 | 3 | -$0.81 | -$0.69 | -$0.75 |
| Q2 2025 | 2 | -$1.22 | -$0.19 | -$0.73 |
| Q3 2025 | 2 | -$1.24 | -$0.19 | -$0.74 |
| Q4 2025 | 2 | -$1.34 | -$0.21 | -$0.80 |
Repare Therapeutics Inc. Earnings Date And Information
Repare Therapeutics Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.81 earnings per share for the quarter, topping analysts' consensus estimates of $-0.83 by $0.02. The company had revenue of 0 for the quarter and had revenue of 51.13 M for the year. Repare Therapeutics Inc. has generated $-2 earnings per share over the last year ($-2.23 diluted earnings per share) and currently has a price-to-earnings ratio of -1.42. Repare Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Repare Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.83 | -$0.81 | 0.02 | $2.73 M | $0 |
| 08/06/2024 | Q2 2024 | -$0.85 | -$0.82 | 0.03 | $2.92 M | $1.07 M |
| 05/07/2024 | Q1 2024 | $0.02 | $0.31 | 0.29 | $52.40 M | |
| 02/28/2024 | Q4 2023 | -$0.56 | -$0.67 | -0.11 | $13.05 M | |
| 11/09/2023 | Q3 2023 | -$0.86 | -$0.45 | 0.41 | $6.31 M | $2.16 M |
| 08/09/2023 | Q2 2023 | -$0.83 | -$0.28 | 0.55 | $7.01 M | $30.25 M |
| 05/09/2023 | Q1 2023 | -$0.84 | -$0.83 | 0.01 | $5.68 M | |
| 02/28/2023 | Q4 2022 | -$0.73 | -$0.75 | -0.02 | $18.20 M | |
| 11/09/2022 | Q3 2022 | -$0.89 | $1.80 | 2.69 | $1.98 M | $112.55 M |
| 08/04/2022 | Q2 2022 | -$0.86 | -$0.91 | -0.05 | $5.43 M | $679,000 |
| 05/05/2022 | Q1 2022 | -$0.89 | -$0.83 | 0.06 | $408,000 | |
| 03/01/2022 | Q4 2021 | -$0.75 | -$0.71 | 0.04 | $6.88 M | |
| 11/10/2021 | Q3 2021 | -$0.70 | -$0.83 | -0.13 | $244,750 | $278,000 |
| 08/12/2021 | Q2 2021 | -$0.58 | -$0.71 | -0.13 | $1.00 M | $279,000 |
| 05/13/2021 | Q1 2021 | -$0.49 | -$0.58 | -0.09 | $166,000 | |
| 03/04/2021 | Q4 2020 | -$0.41 | -$0.41 | 0 | $135,000 | |
| 11/12/2020 | Q3 2020 | -$0.37 | $1.25 M | $0 | ||
| 08/13/2020 | Q2 2020 | -$0.06 | -$2.45 | -2.39 | $0 | |
| 03/30/2020 | Q1 2020 | -$0.40 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.36 | $0 |
Repare Therapeutics Inc. Earnings: Frequently Asked Questions
-
When is Repare Therapeutics Inc.'s earnings date?
Repare Therapeutics Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
-
Did Repare Therapeutics Inc. beat their earnings estimates last quarter?
In the previous quarter, Repare Therapeutics Inc. (:RPTX) reported $-0.81 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.83 by $0.02.
-
How can I listen to Repare Therapeutics Inc.'s earnings conference call?
The conference call for Repare Therapeutics Inc.'s latest earnings report can be listened to online.
-
How can I read Repare Therapeutics Inc.'s conference call transcript?
The conference call transcript for Repare Therapeutics Inc.'s latest earnings report can be read online.
-
How much revenue does Repare Therapeutics Inc. generate each year?
Repare Therapeutics Inc. (:RPTX) has a recorded annual revenue of $51.13 M.
-
How much profit does Repare Therapeutics Inc. generate each year?
Repare Therapeutics Inc. (:RPTX) has a recorded net income of $51.13 M. Repare Therapeutics Inc. has generated $-2.23 earnings per share over the last four quarters.
-
What is Repare Therapeutics Inc.'s price-to-earnings ratio?
Repare Therapeutics Inc. (:RPTX) has a price-to-earnings ratio of -1.42 and price/earnings-to-growth ratio is 0.06.
